Real Heart
Research Real Heart (HEART) on Bullrun: market cap SEK 148.71M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHEART
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 148.71M
- Financial periodQ2 2025
- RevenueSEK 0
- Net income-SEK 8.73M
- Free cash flow-SEK 8.57M
Valuation Snapshot
latest market cap is SEK 148.71M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-05 | SEK 148.71M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Real Heart
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Real Heart's market cap?
Real Heart's market capitalization is SEK 148.71M.
What does Real Heart do?
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.